← Back to Search

Behavioural Intervention

MSCopilot® App for Multiple Sclerosis (MS-DETECT Trial)

N/A

Recruiting

Research Sponsored by Ad scientiam

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at home (day 1, month 6+1 day, month 12 + 1 day, month 18-1 day and month 24-1 day (if applicable)) and in-clinic ((day 0, month 6, month 12, month 18 and month 24 (if applicable))

Awards & highlights

MS-DETECT Trial Summary

This trial will evaluate a smartphone app that remotely monitors Multiple Sclerosis (MS) disease progression, aiming to accurately assess symptoms and predict changes in disability. Patients will use the app and complete tests every 3 months. 243 MS patients from the US, Canada, Germany, Italy, Spain, Denmark & France will be included.

Who is the study for?

This trial is for adults aged 30-65 living with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis, who've been stable for the last 3 months and have an EDSS score of 2.5 to 6.5. Participants must own a smartphone compatible with the MSCopilot® Detect app, be able to use it effectively, and not be pregnant or nursing.Check my eligibility

What is being tested?

The study tests MSCopilot® Detect, a mobile app designed for MS patients to monitor their disease progression at home. It aims to standardize remote monitoring by assessing changes in symptoms and predicting shifts in disability status through digital questionnaires and tests.See study design

What are the potential side effects?

Since this trial involves using a smartphone application rather than medication, traditional side effects are not expected. However, users may experience issues related to usability such as eye strain or stress from regular self-monitoring.

MS-DETECT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at home (day 1, month 6+1 day, month 12 + 1 day, month 18-1 day and month 24-1 day (if applicable)) and in-clinic ((day 0, month 6, month 12, month 18 and month 24 (if applicable))

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at home (day 1, month 6+1 day, month 12 + 1 day, month 18-1 day and month 24-1 day (if applicable)) and in-clinic ((day 0, month 6, month 12, month 18 and month 24 (if applicable))

This trial's timeline: 3 weeks for screening, Varies for treatment, and at home (day 1, month 6+1 day, month 12 + 1 day, month 18-1 day and month 24-1 day (if applicable)) and in-clinic ((day 0, month 6, month 12, month 18 and month 24 (if applicable)) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To evaluate MSCopilot® Detect individual scores and/or composite scores sensitivity to detect disability worsening based on revised-MSFC scores.

Secondary outcome measures

To assess reliability of MSCopilot® Detect individual scores and/or composite scores at-home over time.

To assess reproducibility of MSCopilot® Detect individual scores and/or composite scores between in-clinic and at-home digital tests.

To assess the satisfaction and user experience with the MSCopilot® Detect smartphone application and the MSCopilot® Detect web dashboard.

+11 more

MS-DETECT Trial Design

1Treatment groups

Experimental Treatment

Group I: MSCopilot® DetectExperimental Treatment1 Intervention

Performance of digital tests and standard test in clinic at D0, M6, M12, M18 and M24 (if applicable) Use of MSCopilot® Detect at-home in between visits during 18 or 24 months (if applicable)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ad scientiamLead Sponsor

10 Previous Clinical Trials

1,230 Total Patients Enrolled

2 Trials studying Multiple Sclerosis

252 Patients Enrolled for Multiple Sclerosis

Media Library

MSCopilot® mobile application (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05816122 — N/A

Multiple Sclerosis Research Study Groups: MSCopilot® Detect

Multiple Sclerosis Clinical Trial 2023: MSCopilot® mobile application Highlights & Side Effects. Trial Name: NCT05816122 — N/A

MSCopilot® mobile application (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05816122 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age of 55 and over qualify for participation in this investigation?

"This study is open to participants aged between 30 and 65 years."

Answered by AI

Are there a plethora of Canadian medical institutions running this clinical investigation?

"Seven medical centres are enrolling patients for this trial, including St. Michael's Hospital in Toronto, University Hospital of Southern Denmark in Esbjerg, Hôpital Roger Salengro in Lille; and four other sites across the world."

Answered by AI

Are there opportunities for individuals to partake in this medical investigation?

"According to the clinicaltrials.gov posting, this particular medical trial is not taking on any more participants at present time. It was initially published on June 30th 2023 and its latest update came out April 3rd of that same year. Nevertheless, there are presently 535 different studies recruiting patients from across the world."

Answered by AI

What are the criteria for participation in this medical trial?

"This medical study is recruiting 243 individuals who have multiple sclerosis and are between 30-65 years old. The ideal candidates should also meet the following criteria: be adults with RRMS or SPMS, EDSS score must range from 2.5 to 6.5 points, disease duration needs to exceed 5 years, and they should already be receiving optimal symptomatic treatments beforehand (as judged by a clinician)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect

2023. "MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05816122.